Published in Cancer Weekly, August 17th, 2004
Spectrum says it never applied for a listing nor authorize the listing of its shares on the Berlin Exchange. Furthermore, the company did not authorize or direct any German broker to act as a market maker for the company's common stock.
"We do not believe that a listing on the Berlin Exchange provides value to our shareholders and, therefore, we've undertaken this step in an effort to protect the company and our shareholders," stated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.